Prescription drug · ANDA
paroxetine hydrochloride NDC 71335-9650
Paroxetine hydrochloride hemihydrate 30 mg/1 · Tablet, Film coated · Oral · Bryant Ranch Prepack
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 71335-9650-1 | 71335965001 | 30 TABLET, FILM COATED in 1 BOTTLE (71335-9650-1)Marketed from Mar 28, 2023 | |
| 71335-9650-2 | 71335965002 | 60 TABLET, FILM COATED in 1 BOTTLE (71335-9650-2)Marketed from Sep 6, 2024 | |
| 71335-9650-3 | 71335965003 | 90 TABLET, FILM COATED in 1 BOTTLE (71335-9650-3)Marketed from Sep 6, 2024 | |
| 71335-9650-4 | 71335965004 | 180 TABLET, FILM COATED in 1 BOTTLE (71335-9650-4)Marketed from Sep 6, 2024 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- paroxetine hydrochloride
- Generic name (nonproprietary)
- paroxetine hydrochloride
- Active ingredients
- Paroxetine hydrochloride hemihydrate — 30 mg/1
- Dosage form
- Tablet, Film coated
- Route
- Oral
- Labeler
- Bryant Ranch Prepack
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 076968
- Marketing start
- Listing expires
- Other FDA classes
- Serotonin Uptake Inhibitors (Mechanism)
- Identifiers
- Product ID 71335-9650_52e74299-f193-408d-9d0d-e48398a1734aSPL ID 52e74299-f193-408d-9d0d-e48398a1734aSPL set ID c3c204df-6b7d-42fb-8794-4f38064ed963RxCUI 1738503UNII X2ELS050D8
- Pharmacologic class
- Serotonin Reuptake Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N471335965001followed by a unit qualifier and the quantityPackage 71335-9650-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Paroxetine is a selective serotonin reuptake inhibitor (SSRI) indicated in adults for the treatment of ( 1 ): Major Depressive Disorder (MDD) Obsessive Compulsive Disorder (OCD) Panic Disorder (PD) Social Anxiety Disorder (SAD) Generalized Anxiety Disorder (GAD) Posttraumatic Stress Disorder (PTSD) Paroxetine is indicated in adults for the treatment of: Major depressive disorder (MDD) Obsessive compulsive disorder (OCD) Panic disorder (PD) Social anxiety disorder (SAD) Generalized anxiety disorder (GAD) Posttraumatic stress disorder (PTSD)
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 076968
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| paroxetine hydrochloride | Paroxetine hydrochloride 10 mg/1 | Tablet, Film coatedOral | Oxford Pharmaceuticals, LLC | 69584-671 |
| paroxetine hydrochloride | Paroxetine hydrochloride 20 mg/1 | Tablet, Film coatedOral | Oxford Pharmaceuticals, LLC | 69584-672 |
| paroxetine hydrochloride | Paroxetine hydrochloride 30 mg/1 | Tablet, Film coatedOral | Oxford Pharmaceuticals, LLC | 69584-673 |
| paroxetine hydrochloride | Paroxetine hydrochloride 40 mg/1 | Tablet, Film coatedOral | Oxford Pharmaceuticals, LLC | 69584-674 |